China Hematopoietic Stem Cells Transplantation Market Report & Forecast 2021-2027

Publisher Name :
Date: 23-Aug-2021
No. of pages: 92
Inquire Before Buying

This report contains market size and forecasts of Hematopoietic Stem Cells Transplantation in China, including the following market information:

China Hematopoietic Stem Cells Transplantation Market Revenue, 2016-2021, 2022-2027, ($ millions)

China top five Hematopoietic Stem Cells Transplantation companies in 2020 (%)

The global Hematopoietic Stem Cells Transplantation market size is expected to growth from US$ 2286.8 million in 2020 to US$ 3371 million by 2027; it is expected to grow at a CAGR of 5.7% during 2021-2027.

The China Hematopoietic Stem Cells Transplantation market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the Hematopoietic Stem Cells Transplantation Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

China Hematopoietic Stem Cells Transplantation Market, By Type, 2016-2021, 2022-2027 ($ Millions)

China Hematopoietic Stem Cells Transplantation Market Segment Percentages, By Type, 2020 (%)

- Stem Cells Storage

- Stem Cells Consumables

China Hematopoietic Stem Cells Transplantation Market, By Application, 2016-2021, 2022-2027 ($ Millions)

China Hematopoietic Stem Cells Transplantation Market Segment Percentages, By Application, 2020 (%)

- Leukemia

- Lymphoproliferative Disorders

- Solid Tumors

- Non-Malignant Disorders

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hematopoietic Stem Cells Transplantation revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Hematopoietic Stem Cells Transplantation revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- CBR Systems

- China Cord Blood Corporation

- ViaCord

- Thermo Fisher Scientific

- STEMCELL Technologies

- Vcanbio

- Merck Millipore

- Lonza Group

- CellGenix Technologie Transfer

- ThermoGenesis

China Hematopoietic Stem Cells Transplantation Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Hematopoietic Stem Cells Transplantation Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Hematopoietic Stem Cells Transplantation Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Hematopoietic Stem Cells Transplantation Overall Market Size
2.1 China Hematopoietic Stem Cells Transplantation Market Size: 2021 VS 2027
2.2 China Hematopoietic Stem Cells Transplantation Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hematopoietic Stem Cells Transplantation Players in China Market
3.2 Top China Hematopoietic Stem Cells Transplantation Companies Ranked by Revenue
3.3 China Hematopoietic Stem Cells Transplantation Revenue by Companies
3.4 Top 3 and Top 5 Hematopoietic Stem Cells Transplantation Companies in China Market, by Revenue in 2020
3.5 Companies Hematopoietic Stem Cells Transplantation Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hematopoietic Stem Cells Transplantation Players in China Market
3.6.1 List of Tier 1 Hematopoietic Stem Cells Transplantation Companies in China
3.6.2 List of Tier 2 and Tier 3 Hematopoietic Stem Cells Transplantation Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Hematopoietic Stem Cells Transplantation Market Size Markets, 2021 & 2027
4.1.2 Stem Cells Storage
4.1.3 Stem Cells Consumables
4.2 By Type - China Hematopoietic Stem Cells Transplantation Revenue & Forecasts
4.2.1 By Type - China Hematopoietic Stem Cells Transplantation Revenue, 2016-2021
4.2.2 By Type - China Hematopoietic Stem Cells Transplantation Revenue, 2022-2027
4.2.3 By Type - China Hematopoietic Stem Cells Transplantation Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Hematopoietic Stem Cells Transplantation Market Size, 2021 & 2027
5.1.2 Leukemia
5.1.3 Lymphoproliferative Disorders
5.1.4 Solid Tumors
5.1.5 Non-Malignant Disorders
5.2 By Application - China Hematopoietic Stem Cells Transplantation Revenue & Forecasts
5.2.1 By Application - China Hematopoietic Stem Cells Transplantation Revenue, 2016-2021
5.2.2 By Application - China Hematopoietic Stem Cells Transplantation Revenue, 2022-2027
5.2.3 By Application - China Hematopoietic Stem Cells Transplantation Revenue Market Share, 2016-2027
6 Hematopoietic Stem Cells Transplantation Companies Profiles
6.1 CBR Systems
6.1.1 CBR Systems Company Details
6.1.2 CBR Systems Business Overview
6.1.3 CBR Systems Hematopoietic Stem Cells Transplantation Introduction
6.1.4 CBR Systems Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021)
6.1.5 CBR Systems Recent Developments
6.2 China Cord Blood Corporation
6.2.1 China Cord Blood Corporation Company Details
6.2.2 China Cord Blood Corporation Business Overview
6.2.3 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Introduction
6.2.4 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021)
6.2.5 China Cord Blood Corporation Recent Developments
6.3 ViaCord
6.3.1 ViaCord Company Details
6.3.2 ViaCord Business Overview
6.3.3 ViaCord Hematopoietic Stem Cells Transplantation Introduction
6.3.4 ViaCord Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021)
6.3.5 ViaCord Recent Developments
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Company Details
6.4.2 Thermo Fisher Scientific Business Overview
6.4.3 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Introduction
6.4.4 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021)
6.4.5 Thermo Fisher Scientific Recent Developments
6.5 STEMCELL Technologies
6.5.1 STEMCELL Technologies Company Details
6.5.2 STEMCELL Technologies Business Overview
6.5.3 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Introduction
6.5.4 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021)
6.5.5 STEMCELL Technologies Recent Developments
6.6 Vcanbio
6.6.1 Vcanbio Company Details
6.6.2 Vcanbio Business Overview
6.6.3 Vcanbio Hematopoietic Stem Cells Transplantation Introduction
6.6.4 Vcanbio Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021)
6.6.5 Vcanbio Recent Developments
6.7 Merck Millipore
6.7.1 Merck Millipore Company Details
6.7.2 Merck Millipore Business Overview
6.7.3 Merck Millipore Hematopoietic Stem Cells Transplantation Introduction
6.7.4 Merck Millipore Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021)
6.7.5 Merck Millipore Recent Developments
6.8 Lonza Group
6.8.1 Lonza Group Company Details
6.8.2 Lonza Group Business Overview
6.8.3 Lonza Group Hematopoietic Stem Cells Transplantation Introduction
6.8.4 Lonza Group Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021)
6.8.5 Lonza Group Recent Developments
6.9 CellGenix Technologie Transfer
6.9.1 CellGenix Technologie Transfer Company Details
6.9.2 CellGenix Technologie Transfer Business Overview
6.9.3 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Introduction
6.9.4 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021)
6.9.5 CellGenix Technologie Transfer Recent Developments
6.10 ThermoGenesis
6.10.1 ThermoGenesis Company Details
6.10.2 ThermoGenesis Business Overview
6.10.3 ThermoGenesis Hematopoietic Stem Cells Transplantation Introduction
6.10.4 ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021)
6.10.5 ThermoGenesis Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Hematopoietic Stem Cells Transplantation Market Opportunities & Trends in China Market
Table 2. Hematopoietic Stem Cells Transplantation Market Drivers in China Market
Table 3. Hematopoietic Stem Cells Transplantation Market Restraints in China Market
Table 4. Key Players of Hematopoietic Stem Cells Transplantation in China Market
Table 5. Top Hematopoietic Stem Cells Transplantation Players in China Market, Ranking by Revenue (2019)
Table 6. China Hematopoietic Stem Cells Transplantation Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Hematopoietic Stem Cells Transplantation Revenue Share by Companies, 2016-2021
Table 8. Companies Hematopoietic Stem Cells Transplantation Product Type
Table 9. List of Tier 1 Hematopoietic Stem Cells Transplantation Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Hematopoietic Stem Cells Transplantation Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Hematopoietic Stem Cells Transplantation Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Hematopoietic Stem Cells Transplantation Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Hematopoietic Stem Cells Transplantation Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Hematopoietic Stem Cells Transplantation Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Hematopoietic Stem Cells Transplantation Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Hematopoietic Stem Cells Transplantation Revenue (US$, Mn), 2022-2027
Table 17. CBR Systems Company Details
Table 18. CBR Systems Business Overview
Table 19. CBR Systems Hematopoietic Stem Cells Transplantation Product
Table 20. CBR Systems Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021) & (US$ Million)
Table 21. CBR Systems Recent Developments
Table 22. China Cord Blood Corporation Company Details
Table 23. China Cord Blood Corporation Business Overview
Table 24. China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Product
Table 25. China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021) & (US$ Million)
Table 26. China Cord Blood Corporation Recent Developments
Table 27. ViaCord Company Details
Table 28. ViaCord Business Overview
Table 29. ViaCord Hematopoietic Stem Cells Transplantation Product
Table 30. ViaCord Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021) & (US$ Million)
Table 31. ViaCord Recent Developments
Table 32. Thermo Fisher Scientific Company Details
Table 33. Thermo Fisher Scientific Business Overview
Table 34. Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Product
Table 35. Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Thermo Fisher Scientific Recent Developments
Table 37. STEMCELL Technologies Company Details
Table 38. STEMCELL Technologies Business Overview
Table 39. STEMCELL Technologies Hematopoietic Stem Cells Transplantation Product
Table 40. STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021) & (US$ Million)
Table 41. STEMCELL Technologies Recent Developments
Table 42. Vcanbio Company Details
Table 43. Vcanbio Business Overview
Table 44. Vcanbio Hematopoietic Stem Cells Transplantation Product
Table 45. Vcanbio Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Vcanbio Recent Developments
Table 47. Merck Millipore Company Details
Table 48. Merck Millipore Business Overview
Table 49. Merck Millipore Hematopoietic Stem Cells Transplantation Product
Table 50. Merck Millipore Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Merck Millipore Recent Developments
Table 52. Lonza Group Company Details
Table 53. Lonza Group Business Overview
Table 54. Lonza Group Hematopoietic Stem Cells Transplantation Product
Table 55. Lonza Group Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Lonza Group Recent Developments
Table 57. CellGenix Technologie Transfer Company Details
Table 58. CellGenix Technologie Transfer Business Overview
Table 59. CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Product
Table 60. CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021) & (US$ Million)
Table 61. CellGenix Technologie Transfer Recent Developments
Table 62. ThermoGenesis Company Details
Table 63. ThermoGenesis Business Overview
Table 64. ThermoGenesis Hematopoietic Stem Cells Transplantation Product
Table 65. ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue in China Market (2016-2021) & (US$ Million)
Table 66. ThermoGenesis Recent Developments
List of Figures
Figure 1. Hematopoietic Stem Cells Transplantation Segment by Type
Figure 2. Hematopoietic Stem Cells Transplantation Segment by Application
Figure 3. China Hematopoietic Stem Cells Transplantation Market Overview: 2020
Figure 4. China Hematopoietic Stem Cells Transplantation Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Hematopoietic Stem Cells Transplantation Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Hematopoietic Stem Cells Transplantation Revenue in 2020
Figure 7. By Type - China Hematopoietic Stem Cells Transplantation Revenue Market Share, 2016-2027
Figure 8. By Application - China Hematopoietic Stem Cells Transplantation Revenue Market Share, 2016-2027
Figure 9. CBR Systems Hematopoietic Stem Cells Transplantation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. ViaCord Hematopoietic Stem Cells Transplantation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Vcanbio Hematopoietic Stem Cells Transplantation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Merck Millipore Hematopoietic Stem Cells Transplantation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Lonza Group Hematopoietic Stem Cells Transplantation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs